5B9, a monoclonal anti-platelet factor 4 /heparin IgG with a human Fc fragment that mimics heparin-induced thrombocytopenia antibodies - CNRS - Centre national de la recherche scientifique Accéder directement au contenu
Article Dans Une Revue Journal of Thrombosis and Haemostasis Année : 2017

5B9, a monoclonal anti-platelet factor 4 /heparin IgG with a human Fc fragment that mimics heparin-induced thrombocytopenia antibodies

Résumé

The diagnosis of heparin-induced thrombocytopenia (HIT) is based on clinical and biological criteria, but a standard is lacking for laboratory assays. Moreover, no humanized HIT antibody is available for pathophysiological studies. To characterise 5B9, a chimeric monoclonal antibody, which fully mimics the effects of human HIT antibodies. 5B9, a chimeric anti-PF4/H IgG1 antibody was obtained after immunizing specific transgenic mice. 5B9 induced heparin FcγRIIA-dependent platelet aggregation and tissue factor mRNA synthesis in monocytes. It also induced significant thrombocytopenia and thrombin generation in mice expressing human PF4 and FcγRIIA receptors. The binding of 5B9 to PF4/H complexes was inhibited by 15 of 25 HIT plasma samples and only 3 of 25 samples containing non-pathogenic anti-PF4/H antibodies. KKO, a murine IgG2b HIT antibody, also inhibited the binding of 5B9 to PF4/H, suggesting that epitopes recognized by both antibodies are close. A docking analysis based on VH and VL sequences of 5B9 showed that binding of 5B9 Fab to PF4 involved 12 and 12 residues in B and D monomers, respectively, including 7 previously identified as critical to the formation of a PF4/KKO complex. Two regions (Asp-7 to Thr-15 and Ala-32 to Thr-38) therefore appeared important for the binding of 5B9 and KKO on PF4 modified by heparin. 5B9 is the first anti-PF4/H monoclonal antibody with a human Fc fragment, which induces similar cellular activation as HIT antibodies. Moreover, 5B9 binds epitopes within PF4 that are likely critical for the pathogenicity of HIT antibodies.
Fichier principal
Vignette du fichier
2017_Kizlik-Masson_JThrombosisHaemostasis_1.pdf (524.75 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)
Loading...

Dates et versions

hal-01601420 , version 1 (26-05-2020)

Licence

Copyright (Tous droits réservés)

Identifiants

Citer

C. Kizlik-Masson, C. Vayne, S.E. Mckenzie, Anne Poupon, Y. Zhou, et al.. 5B9, a monoclonal anti-platelet factor 4 /heparin IgG with a human Fc fragment that mimics heparin-induced thrombocytopenia antibodies. Journal of Thrombosis and Haemostasis, 2017, 15 (10), pp.1-28. ⟨10.1111/jth.13786⟩. ⟨hal-01601420⟩
189 Consultations
174 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More